Schroder Investment Management Group
BLUE

Schroder Investment Management Group’s bluebird bio BLUE Stock Holding History

Schroder Investment Management Group’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-5,953
Closed -$2.32M – 1523
2021
Q1 		$2.32M Buy
+5,953
New +$2.93M ﹤0.01% 980
2017
Q2 		– Sell
-488
Closed -$580K – 1286
2017
Q1 		$580K Sell
488
-500
-51% -$510K ﹤0.01% 1005
2016
Q4 		$790K Sell
988
-306
-24% -$243K ﹤0.01% 939
2016
Q3 		$1.14M Sell
1,294
-653
-34% -$473K ﹤0.01% 908
2016
Q2 		$1.09M Buy
+1,947
New +$1.1M ﹤0.01% 891

Other funds holding BLUE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Schroder Investment Management Group's BLUE Position: Q2 2021 in Review

Schroder Investment Management Group sold out of bluebird bio (BLUE) in Q2 2021, closing a stake of 5,953 shares — an estimated $2.32M sold.

Schroder Investment Management Group first reported a position in BLUE in Q2 2016 and held it in 5 quarters. The position peaked at $2.32M in Q1 2021. 232 funds tracked by Wall St. Rank hold BLUE as of Q2 2021.

  • Schroder Investment Management Group reported no remaining bluebird bio position as of Q2 2021 after selling out during the quarter.
  • Schroder Investment Management Group sold 5,953 bluebird bio shares in Q2 2021, an estimated $2.32M.
  • Schroder Investment Management Group first reported a position in bluebird bio in Q2 2016 and held it in 5 quarters.
  • Schroder Investment Management Group's bluebird bio position peaked at $2.32M in Q1 2021.
  • 232 funds tracked by Wall St. Rank held bluebird bio as of Q2 2021.

Based on Schroder Investment Management Group's 13F filing for Q2 2021, filed 13 Aug 2021.